Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CamKid
2023-508516-34-00Phase 2Completed
- Sponsor
- University Hospital Odense
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of camostat mesilate in chronic kidney disease (CKD), sponsored by University Hospital Odense. Primary endpoints: Urine sodium excretion, Water excretion and 2 more. Started Mar 2024; status: completed.
02
Drugs
camostat mesilate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2023-508516-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508516-34-00.